Nuveen California Municipal Value Fund
Change company Symbol lookup
Select an option...
NCA Nuveen California Municipal Value Fund
SGOL abrdn Physical Gold Shares ETF
GAB-K Gabelli Equity Trust Inc
GAB-H Gabelli Equity Trust Inc
GAB-G Gabelli Equity Trust Inc
AAL American Airlines Group Inc
ARKF ARK Fintech Innovation ETF
PNR Pentair PLC
AMD Advanced Micro Devices Inc
IDAI T Stamp Inc
Go

Nuveen California Municipal Value Fund, Inc. (the Fund) is a diversified, closed-end management investment company. The Fund's objective is to seeks current income exempt from both regular federal income taxes and California personal income tax. Its secondary investment objective is the enhancement of portfolio value. The Fund invests in municipal securities that are exempt from federal and California state income taxes. The Fund invests at least 80% of its managed assets in securities rated, at the time of investment, investment grade or, if they are unrated, are judged by the manager to be of comparable quality. The Fund also invest up to 20% of its managed assets in municipal securities rated below investment quality or judged by the manager to be of comparable quality, of which up to 10% of its managed assets may be rated below B-/B3 or of comparable quality. It also invests in inverse floating rate municipal securities. Its investment adviser is Nuveen Fund Advisors, LLC.

Price: Delayed
$8.73

Day's Change: 0.01 (0.11%)

Bid: --

Ask: --

B/A Size: --

Day's High: 8.82

Day's Low: 8.68

Volume (Heavy Day) Today's volume of 45,107 shares is on pace to be much greater than NCA's 10-day average volume of 51,221 shares.: 45,107

AbbVie Inc. Stock Falls Tuesday, Underperforms Market

4:33 pm ET January 17, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of AbbVie Inc. (ABBV) dropped 0.50% to $152.83 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.20% to 3,990.97 and Dow Jones Industrial Average falling 1.14% to 33,910.85. AbbVie Inc. closed $23.08 short of its 52-week high ($175.91), which the company reached on April 8th.

Despite its losses, the stock outperformed some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.62% to $172.36 and Pfizer Inc. (PFE) fell 3.70% to $46.08. Trading volume (7.5 M) eclipsed its 50-day average volume of 5.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 17, 2023.

(END) Dow Jones Newswires

January 17, 2023 16:33 ET (21:33 GMT)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and